This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
An index aggregates a group of stocks to reflect overall market or sector performance. This explanation covers purpose, construction, and uses.
27,346 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Boone Capital just disclosed a fresh position in HealthEquity, raising questions about the stock's potential. This gu...
Disney's stock is under renewed pressure as its core businesses face slower growth. The market is awaiting clearer pr...
This deep dive analyzes the poci 2026 earnings transcript, translating quarterly numbers into real-world implications...
When a hedge fund takes position in a logistics stock, it often signals confidence in the sector's growth prospects a...
When top executives trim stakes, investors take note. This article breaks down the meaning behind such moves, with a ...
In 2026, two very different gaming plays compete for attention: Roblox as a high-growth platform and GameStop as a tu...
AMD has delivered a staggering run, rising nearly 300% over past year. This article breaks down whether the momentum ...
Alaska Air Group stock surged this week as investors weighed fuel-cost pressures against resilient demand and discipl...
Among the market’s biggest names, only a few of the so-called magnficent seven look like buys today. This piece digs ...
Micron Technology has powered higher this year on AI demand, delivering a staggering rally. Yet veteran traders urge ...
After the first quarter, the sharkninja 2026 earnings call reveals a company balancing strong demand with cost pressu...